Company Filing History:
Years Active: 2022
Title: Capucine Trollet: Innovator in RNA Interference for OPMD Treatment
Introduction
Capucine Trollet is a prominent inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the treatment of oculopharyngeal muscular dystrophy (OPMD). Her innovative work focuses on developing RNA interference (RNAi) reagents that offer new hope for individuals suffering from this condition.
Latest Patents
Capucine Trollet holds a patent for "Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof." This patent details RNA interference reagents designed to treat individuals affected by OPMD or those predisposed to the disease. The compositions and methods outlined in her patent represent a significant advancement in therapeutic options for this rare muscular disorder.
Career Highlights
Throughout her career, Capucine has been associated with Benitec Biopharma Limited, a company dedicated to developing innovative therapies using RNAi technology. Her work has positioned her as a key figure in the field of genetic research and therapeutic development.
Collaborations
Capucine Trollet has collaborated with notable professionals in her field, including David A Suhy and Michael Graham. These partnerships have enhanced her research efforts and contributed to the advancement of RNAi therapies.
Conclusion
Capucine Trollet's contributions to the treatment of oculopharyngeal muscular dystrophy through her innovative patent highlight her role as a leading inventor in the field of medical research. Her work continues to inspire advancements in therapeutic solutions for rare diseases.